100 related articles for article (PubMed ID: 23739915)
1. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
; Lill CM; Schjeide BM; Graetz C; Ban M; Alcina A; Ortiz MA; Pérez J; Damotte V; Booth D; Lopez de Lapuente A; Broer L; Schilling M; Akkad DA; Aktas O; Alloza I; Antigüedad A; Arroyo R; Blaschke P; Buttmann M; Chan A; Compston A; Cournu-Rebeix I; Dörner T; Epplen JT; Fernández Ó; Gerdes LA; Guillot-Noël L; Hartung HP; Hoffjan S; Izquierdo G; Kemppinen A; Kroner A; Kubisch C; Kümpfel T; Li SC; Lindenberger U; Lohse P; Lubetzki C; Luessi F; Malhotra S; Mescheriakova J; Montalban X; Papeix C; Paredes LF; Rieckmann P; Steinhagen-Thiessen E; Winkelmann A; Zettl UK; Hintzen R; Vandenbroeck K; Stewart G; Fontaine B; Comabella M; Urcelay E; Matesanz F; Sawcer S; Bertram L; Zipp F
Brain; 2013 Jun; 136(Pt 6):1778-82. PubMed ID: 23739915
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Patsopoulos NA; ; ; ; ; ; Esposito F; Reischl J; Lehr S; Bauer D; Heubach J; Sandbrink R; Pohl C; Edan G; Kappos L; Miller D; Montalbán J; Polman CH; Freedman MS; Hartung HP; Arnason BG; Comi G; Cook S; Filippi M; Goodin DS; Jeffery D; O'Connor P; Ebers GC; Langdon D; Reder AT; Traboulsee A; Zipp F; Schimrigk S; Hillert J; Bahlo M; Booth DR; Broadley S; Brown MA; Browning BL; Browning SR; Butzkueven H; Carroll WM; Chapman C; Foote SJ; Griffiths L; Kermode AG; Kilpatrick TJ; Lechner-Scott J; Marriott M; Mason D; Moscato P; Heard RN; Pender MP; Perreau VM; Perera D; Rubio JP; Scott RJ; Slee M; Stankovich J; Stewart GJ; Taylor BV; Tubridy N; Willoughby E; Wiley J; Matthews P; Boneschi FM; Compston A; Haines J; Hauser SL; McCauley J; Ivinson A; Oksenberg JR; Pericak-Vance M; Sawcer SJ; De Jager PL; Hafler DA; de Bakker PI
Ann Neurol; 2011 Dec; 70(6):897-912. PubMed ID: 22190364
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.
Mells GF; Floyd JA; Morley KI; Cordell HJ; Franklin CS; Shin SY; Heneghan MA; Neuberger JM; Donaldson PT; Day DB; Ducker SJ; Muriithi AW; Wheater EF; Hammond CJ; Dawwas MF; ; ; Jones DE; Peltonen L; Alexander GJ; Sandford RN; Anderson CA
Nat Genet; 2011 Mar; 43(4):329-32. PubMed ID: 21399635
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
De Jager PL; Jia X; Wang J; de Bakker PI; Ottoboni L; Aggarwal NT; Piccio L; Raychaudhuri S; Tran D; Aubin C; Briskin R; Romano S; ; Baranzini SE; McCauley JL; Pericak-Vance MA; Haines JL; Gibson RA; Naeglin Y; Uitdehaag B; Matthews PM; Kappos L; Polman C; McArdle WL; Strachan DP; Evans D; Cross AH; Daly MJ; Compston A; Sawcer SJ; Weiner HL; Hauser SL; Hafler DA; Oksenberg JR
Nat Genet; 2009 Jul; 41(7):776-82. PubMed ID: 19525953
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study of severity in multiple sclerosis.
International Multiple Sclerosis Genetics Consortium
Genes Immun; 2011 Dec; 12(8):615-25. PubMed ID: 21654844
[TBL] [Abstract][Full Text] [Related]
6. The A Allele of the Single-Nucleotide Polymorphism rs630923 Creates a Binding Site for MEF2C Resulting in Reduced CXCR5 Promoter Activity in B-Cell Lymphoblastic Cell Lines.
Mitkin NA; Muratova AM; Schwartz AM; Kuprash DV
Front Immunol; 2016; 7():515. PubMed ID: 27909439
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Multiple Sclerosis: An Overview and New Directions.
Patsopoulos NA
Cold Spring Harb Perspect Med; 2018 Jul; 8(7):. PubMed ID: 29440325
[TBL] [Abstract][Full Text] [Related]
8. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility.
Bush WS; McCauley JL; DeJager PL; Dudek SM; Hafler DA; Gibson RA; Matthews PM; Kappos L; Naegelin Y; Polman CH; Hauser SL; Oksenberg J; Haines JL; Ritchie MD;
Genes Immun; 2011 Jul; 12(5):335-40. PubMed ID: 21346779
[TBL] [Abstract][Full Text] [Related]
9. What role for genetics in the prediction of multiple sclerosis?
Sawcer S; Ban M; Wason J; Dudbridge F
Ann Neurol; 2010 Jan; 67(1):3-10. PubMed ID: 20186855
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association studies of multiple sclerosis.
Cotsapas C; Mitrovic M
Clin Transl Immunology; 2018; 7(6):e1018. PubMed ID: 29881546
[TBL] [Abstract][Full Text] [Related]
11. A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
Korn T; Oukka M
N Engl J Med; 2017 Apr; 376(17):1680-1681. PubMed ID: 28445672
[No Abstract] [Full Text] [Related]
12. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
; Beecham AH; Patsopoulos NA; Xifara DK; Davis MF; Kemppinen A; Cotsapas C; Shah TS; Spencer C; Booth D; Goris A; Oturai A; Saarela J; Fontaine B; Hemmer B; Martin C; Zipp F; D'Alfonso S; Martinelli-Boneschi F; Taylor B; Harbo HF; Kockum I; Hillert J; Olsson T; Ban M; Oksenberg JR; Hintzen R; Barcellos LF; ; ; Agliardi C; Alfredsson L; Alizadeh M; Anderson C; Andrews R; Søndergaard HB; Baker A; Band G; Baranzini SE; Barizzone N; Barrett J; Bellenguez C; Bergamaschi L; Bernardinelli L; Berthele A; Biberacher V; Binder TM; Blackburn H; Bomfim IL; Brambilla P; Broadley S; Brochet B; Brundin L; Buck D; Butzkueven H; Caillier SJ; Camu W; Carpentier W; Cavalla P; Celius EG; Coman I; Comi G; Corrado L; Cosemans L; Cournu-Rebeix I; Cree BA; Cusi D; Damotte V; Defer G; Delgado SR; Deloukas P; di Sapio A; Dilthey AT; Donnelly P; Dubois B; Duddy M; Edkins S; Elovaara I; Esposito F; Evangelou N; Fiddes B; Field J; Franke A; Freeman C; Frohlich IY; Galimberti D; Gieger C; Gourraud PA; Graetz C; Graham A; Grummel V; Guaschino C; Hadjixenofontos A; Hakonarson H; Halfpenny C; Hall G; Hall P; Hamsten A; Harley J; Harrower T; Hawkins C; Hellenthal G; Hillier C; Hobart J; Hoshi M; Hunt SE; Jagodic M; Jelčić I; Jochim A; Kendall B; Kermode A; Kilpatrick T; Koivisto K; Konidari I; Korn T; Kronsbein H; Langford C; Larsson M; Lathrop M; Lebrun-Frenay C; Lechner-Scott J; Lee MH; Leone MA; Leppä V; Liberatore G; Lie BA; Lill CM; Lindén M; Link J; Luessi F; Lycke J; Macciardi F; Männistö S; Manrique CP; Martin R; Martinelli V; Mason D; Mazibrada G; McCabe C; Mero IL; Mescheriakova J; Moutsianas L; Myhr KM; Nagels G; Nicholas R; Nilsson P; Piehl F; Pirinen M; Price SE; Quach H; Reunanen M; Robberecht W; Robertson NP; Rodegher M; Rog D; Salvetti M; Schnetz-Boutaud NC; Sellebjerg F; Selter RC; Schaefer C; Shaunak S; Shen L; Shields S; Siffrin V; Slee M; Sorensen PS; Sorosina M; Sospedra M; Spurkland A; Strange A; Sundqvist E; Thijs V; Thorpe J; Ticca A; Tienari P; van Duijn C; Visser EM; Vucic S; Westerlind H; Wiley JS; Wilkins A; Wilson JF; Winkelmann J; Zajicek J; Zindler E; Haines JL; Pericak-Vance MA; Ivinson AJ; Stewart G; Hafler D; Hauser SL; Compston A; McVean G; De Jager P; Sawcer SJ; McCauley JL
Nat Genet; 2013 Nov; 45(11):1353-60. PubMed ID: 24076602
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide significant association with seven novel multiple sclerosis risk loci.
Lill CM; Luessi F; Alcina A; Sokolova EA; Ugidos N; de la Hera B; Guillot-Noël L; Malhotra S; Reinthaler E; Schjeide BM; Mescheriakova JY; Mashychev A; Wohlers I; Akkad DA; Aktas O; Alloza I; Antigüedad A; Arroyo R; Astobiza I; Blaschke P; Boyko AN; Buttmann M; Chan A; Dörner T; Epplen JT; Favorova OO; Fedetz M; Fernández O; García-Martínez A; Gerdes LA; Graetz C; Hartung HP; Hoffjan S; Izquierdo G; Korobko DS; Kroner A; Kubisch C; Kümpfel T; Leyva L; Lohse P; Malkova NA; Montalban X; Popova EV; Rieckmann P; Rozhdestvenskii AS; Schmied C; Smagina IV; Tsareva EY; Winkelmann A; Zettl UK; Binder H; Cournu-Rebeix I; Hintzen R; Zimprich A; Comabella M; Fontaine B; Urcelay E; Vandenbroeck K; Filipenko M; Matesanz F; Zipp F; Bertram L
J Med Genet; 2015 Dec; 52(12):848-55. PubMed ID: 26475045
[TBL] [Abstract][Full Text] [Related]
14. Update on biomarkers in neuromyelitis optica.
Melamed E; Levy M; Waters PJ; Sato DK; Bennett JL; John GR; Hooper DC; Saiz A; Bar-Or A; Kim HJ; Pandit L; Leite MI; Asgari N; Kissani N; Hintzen R; Marignier R; Jarius S; Marcelletti J; Smith TJ; Yeaman MR; Han MH; Aktas O; Apiwattanakul M; Banwell B; Bichuetti D; Broadley S; Cabre P; Chitnis T; De Seze J; Fujihara K; Greenberg B; Hellwig K; Iorio R; Jarius S; Klawiter E; Kleiter I; Lana-Peixoto M; Nakashima ; O'Connor K; Palace J; Paul F; Prayoonwiwat N; Ruprecht K; Stuve O; Tedder T; Tenembaum S; Garrahan JP; Aires B; van Herle K; van Pelt D; Villoslada P; Waubant E; Weinshenker B; Wingerchuk D; Würfel J; Zamvil S
Neurol Neuroimmunol Neuroinflamm; 2015 Aug; 2(4):e134. PubMed ID: 26236760
[TBL] [Abstract][Full Text] [Related]
15. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
Mult Scler; 2015 Jul; 21(8):1013-24. PubMed ID: 25680984
[TBL] [Abstract][Full Text] [Related]
16. Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD; Reingold SC; Cohen JA; Cutter GR; Sørensen PS; Thompson AJ; Wolinsky JS; Balcer LJ; Banwell B; Barkhof F; Bebo B; Calabresi PA; Clanet M; Comi G; Fox RJ; Freedman MS; Goodman AD; Inglese M; Kappos L; Kieseier BC; Lincoln JA; Lubetzki C; Miller AE; Montalban X; O'Connor PW; Petkau J; Pozzilli C; Rudick RA; Sormani MP; Stüve O; Waubant E; Polman CH
Neurology; 2014 Jul; 83(3):278-86. PubMed ID: 24871874
[TBL] [Abstract][Full Text] [Related]
17. A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.
Vollmer TL; Sorensen PS; Selmaj K; Zipp F; Havrdova E; Cohen JA; Sasson N; Gilgun-Sherki Y; Arnold DL;
J Neurol; 2014 Apr; 261(4):773-83. PubMed ID: 24535134
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study.
Doerner M; Beckmann K; Knappertz V; Kappos L; Hartung HP; Filippi M; O'Connor PW; Arnason B; Cook S; Jeffery D; Comi G; Limmroth V
Eur Neurol; 2014; 71(3-4):173-9. PubMed ID: 24457374
[TBL] [Abstract][Full Text] [Related]
19. Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.
Rommer PS; Zettl UK; Kieseier B; Hartung HP; Menge T; Frohman E; Greenberg BM; Hemmer B; Stüve O
Clin Exp Immunol; 2014 Mar; 175(3):397-407. PubMed ID: 24102425
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
